COMPANY
Molecular Theranostics, LLC
Funding and NIH signals
- NIH award NIH awarded $528K (NIH grant 1R01CA297667-01A1, new, notice Aug 20, 2026). NIH RePORTER 1R01CA297667-01A1 (Aug 20, 2026)
Evidence (1 event)
- Aug 20, 2026 · NIH RePORTER 1R01CA297667-01A1
Organization: MOLECULAR THERANOSTICS, LLC; City/State: BEACHWOOD, OH; Project number: 1R01CA297667-01A1; Activity code: R01; Fiscal year: 2026; Award notice date: 2026-08-20; FY total cost (award amount): 528259; Administering IC: National Cancer Institute; Project title: Development of next-generation targeted MRI contrast agents; Organization type: Domestic For-Profits
- Aug 20, 2026 · NIH RePORTER 1R01CA297667-01A1
Timeline
- Grant Government grant — NIH R01: $528,259 (annual award, as published), announced Aug 20, 2026. Agency: NIH/NCI. Source: government award database. source ↗
Funding
- Government grant — NIH R01: $528,259 (annual award, as published), announced Aug 20, 2026. Agency: NIH/NCI. Source: government award database. source ↗